Robert Spiegel
@robertspiegel
Director
Building NexImmune, Inc. as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
NexImmune, Inc. was founded in 2011 and has no closure on record.
Named alongside
- LLC Acuity ManagementExecutive Officer
- Scott KurlandExecutive Officer
- LLC Acuity ManagementExecutive Officer
- Scott KurlandExecutive Officer
- LLC Acuity ManagementExecutive Officer
- Scott KurlandExecutive Officer
- LLC Acuity ManagementExecutive Officer
- Scott KurlandExecutive Officer
- LLC Acuity ManagementExecutive Officer
- Scott KurlandExecutive Officer
At Cyclacel Pharmaceuticals, Inc.
- Avraham Ben-TzviDirector
- Avraham Fock Ben-TzviDirector
- Brian L. SchwartzDirector
- Brian SchwartzDirector
- Christopher HenneyDirector
- Christopher S. HenneyDirector
- Datuk Dr. Doris Wong Sing EeExecutive Officer
- David Fock NatanDirector
- Alain CappelutiExecutive Officer, Director
- Alan RoemerDirector
- Bing YaoDirector
- James BarrettDirector
- Janis NaeveDirector
- Jonathan SchneckDirector
- Kenneth CarterExecutive Officer, Director
- Paul D'AngioDirector
Contribution
Robert's ideas, decisions and failures appear here once this profile is claimed.
Companies
- NexImmune, Inc.Pharmaceutical Preparations; filing with the SEC since 2012Director · Biotechnology · GAITHERSBURG, United States · Founded 2011
- Acuity Nylas LLCExecutive Officer · Business Services · NEW YORK, United States · Founded 2021
- Acuity Tanium LLCExecutive Officer · Other Technology · NEW YORK, United States · Founded 2021
- Acuity DataStax LLCExecutive Officer · Other Technology · NEW YORK, United States · Founded 2021
- ACUITY EPIRUS LLCExecutive Officer · Other · NEW YORK, United States · Founded 2022
- ACUITY TURO LLCExecutive Officer · Other · NEW YORK, United States · Founded 2022
- Cyclacel Pharmaceuticals, Inc.Wholesale-Durable Goods, NEC; formerly Cyclacel Pharmaceuticals, Inc.; listed on Nasdaq as BGMS; filing with the SEC since 2010Director · Biotechnology · BERKELEY HEIGHTS, United States